Clik here to view.
Is the Combination of Immunotherapy and Radiation in Lung Cancer a Feasible...
The biomarker that predicts response to radiation therapy (RT) and immune checkpoint blockade (ICB) treatment combination for lung cancer patients has been identified. In many cancer types, cancer...
View ArticleClik here to view.
Air Pollution is the Main Contributor to Lung Cancer
bHighlights:/b ul class="group-list" li Lung cancer is one of the most prevalent cancers and the leading cause of cancer-related deaths /li li Along with smoking, environmental contaminants like...
View ArticleClik here to view.
US FDA Approves 'Glowing Tumor' Imaging Medication for Lung Cancer Surgery
bHighlights:/b ul class="group-list" li An injectable imaging agent that attaches to lung cancer tissue and glows has been approved by the US Food and Drug Administration /li li This will make it...
View ArticleClik here to view.
Hardy Kiwi Juice Inhibits Lung Cancer
In mouse model, "Sarunashi" (iActinidia arguta/i) juice and its constituting component isoquercetin (isoQ) were found to prevent and decrease lung cancer development. Sarunashi is an edible fruit...
View ArticleClik here to view.
Artificial Intelligence Tool to Predict Lung Cancer Risk
Sybil, the artificial intelligence (AI) tool developed by researchers precisely predicts lung cancer risk for people with or without a significant smoking history. Results are published in the...
View ArticleClik here to view.
Gene Drives Common Lung Cancer Type
KMT2D gene that drives lung cancer development offers fresh insight into how the lung carcinoma might be treated. There is currently no approved, targeted, first-line therapy for lung squamous...
View ArticleClik here to view.
Radiotherapy Benefits Lung Cancer Patients
In patients with early stage lung neuroendocrine tumors, stereotactic body radiotherapy, or SBRT was found to be an effective treatment, stated Moffitt Cancer Center researchers. Primary lung...
View ArticleClik here to view.
New Target for Lung Cancer Treatment Resistance
In EGFR-mutant non-small cell lung cancer (NSCLC), CD70 has been discovered as being highly expressed on drug-resistant cancer cells. The preclinical research was led by Monique Nilsson, Ph.D., and...
View ArticleClik here to view.
Lung Cancer Death Rates Declining in Europe and the United Kingdom
Lung cancer being the most common cause of cancer death in the UK is projected to rise the average number of deaths from lung cancer in the UK every year will from around 36,800 deaths in 2023-2025 to...
View ArticleClik here to view.
Adopting a Conservative Approach to Lung Cancer Surgery
bHighlights:/bul class="group-list punch-points" liLung cancer is by far the leading cause of cancer death in the US, accounting for about 1 in 5 of all cancer deaths/li liThe usual treatment for...
View ArticleClik here to view.
Perioperative Immunotherapy: A Promising Approach for Resectable Lung Cancer
bHighlights:/b ul class="group-list" li Perioperative durvalumab, combined with platinum-based chemotherapy, significantly improved event-free survival and pathologic complete response rates for...
View ArticleClik here to view.
Quitting Smoking Early Linked to Improved Lung Cancer Survival Rates
Following non-small cell lung cancer (NSCLC) diagnosis, medlinkquitting smoking/medlink is linked to increased survival rates, according to a new study led by researchers at Harvard T.H. Chan School...
View ArticleClik here to view.
Two Years: Optimal Duration of Immunotherapy in Advanced Lung Cancer
The introduction of immune checkpoint inhibitors has resulted in a paradigm shift in the management of advanced medlinklung cancer/medlink, resulting in longer patient lives and improved overall...
View ArticleClik here to view.
How Can Blood Test Help Predict Lung Cancer Mortality Risk?
The newly developed blood-based test predicted an individual's dying risk from medlinklung cancer/medlink, stated study published today in the iJournal of Clinical Oncology/i (!--ref1--). "This simple...
View ArticleClik here to view.
World Lung Cancer Day: It's Time to Raise Awareness
bHighlights:/bul class="group-list punch-points"li World Lung Cancer Day is observed on August 1 to raise awareness about lung cancer and its impact on individuals and communities worldwide/li liIt is...
View ArticleClik here to view.
Lung Cancer Patients' Survival May Affect by Wildfire Exposure
Wildfire exposure was associated with worse overall survival of medlinklung cancer/medlink patients following their surgery, suggesting that lung cancer patients are at greater risk from the health...
View ArticleClik here to view.
AstraZeneca's Tagrisso Drug to Rule Lung Cancer Small Molecule Market
Tagrisso, a brand-name medication, the commercial name for medlinkOsimertinib/medlink, is positioned to become a cornerstone of AstraZeneca's portfolio, with anticipated sales exceeding (Dollor) 7...
View ArticleClik here to view.
November: Lung Cancer Awareness Month
bHighlights:/b ul class="group-list" li November's Lung Cancer Awareness Month unites communities to spotlight the challenges and triumphs in the fight against lung cancer /li li This month emphasizes...
View ArticleClik here to view.
Does Family History Heighten Lung Cancer Risk?
Researchers found that for non-smokers, having first-degree relatives with a history of lung cancer elevates the risk of developing lung cancer, especially invasive types with advancing age. The team...
View ArticleClik here to view.
Anti-allergy Drug Dupilumab Treats Lung Cancer
In cases of non-small cell lung cancer, pairing medlinkimmunotherapy/medlink with dupilumab- frequently used to treat allergies and medlinkasthma/medlink improved patients' immune systems and...
View Article